Wakefield, MA, United States of America

Anton Filikov



Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 99(Granted Patents)


Location History:

  • Monrovia, CA (US) (2005 - 2006)
  • San Diego, CA (US) (2006)
  • Wakefield, MA (US) (2006 - 2007)
  • Woburn, MA (US) (2010)

Company Filing History:


Years Active: 2005-2010

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Anton Filikov: Innovator in TNF-alpha Related Treatments

Introduction

Anton Filikov is a notable inventor based in Wakefield, MA (US), recognized for his contributions to the field of biotechnology. He holds a total of 6 patents, focusing primarily on the treatment of TNF-alpha related disorders. His innovative work has the potential to significantly impact therapeutic approaches in this area.

Latest Patents

Filikov's latest patents include groundbreaking inventions related to TNF-alpha variant proteins. One of his notable inventions is titled "Treatment of TNF-α related disorders with TNF-α variant proteins." This invention pertains to novel proteins that exhibit TNF-alpha antagonist activity, along with nucleic acids that encode these proteins. The application of these novel proteins aims to provide effective treatment options for TNF-alpha related disorders. Another significant patent is "TNF-alpha variants proteins for the treatment of TNF-alpha related disorders," which shares similar objectives and innovations in the treatment landscape.

Career Highlights

Throughout his career, Anton Filikov has worked with various organizations, including Xencor, Inc. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Filikov has collaborated with esteemed colleagues such as Bassil I Dahiyat and John R Desjarlais. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in biotechnology.

Conclusion

Anton Filikov's work in the field of TNF-alpha related treatments showcases his dedication to innovation and improvement in medical therapies. His patents reflect a commitment to advancing healthcare solutions, making him a significant figure in the biotechnology industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…